Topics:

HPV

HPV

Urine tests effectively screen for HPV, but more data is needed to determine whether they can correctly diagnose cervical disease.

Be it Pap tests, HPV tests, or both, cervical cancer screening is important. This article explores screening paradigms and offers a glimpse of what's to come.

The FDA has approved bevacizumab (Avastin) for treating persistent, recurrent, or metastatic cervical cancer after studies show gains in overall survival.

The optimal time to get the HPV vaccine is before a first sexual encounter. But getting the vaccine after still offers significant protection against cervical dysplasia.

The American College of Physicians (ACP) recommends against pelvic exams in asymptomatic, nonpregnant, adult women. Some say this is faulty logic. What say you?

Don’t let time constraints and large patient loads prevent you from providing a thorough well-woman visit. Are you covering all the bases?

An FDA panel has recommended that a DNA test that screens for HPV in women can replace the standard Pap smear as a first-line primary cervical cancer screening test.

Pages

Subscribe to HPV on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.